HIMS vs. SNEX
HIMS (Hims & Hers Health, Inc.) and SNEX (StoneX Group Inc.) are both stocks. HIMS operates in Drug Manufacturers - Specialty & Generic (Healthcare), while SNEX operates in Capital Markets (Financial Services). Over the past 5 years, HIMS returned 24.71%/yr vs 49.24%/yr for SNEX. At a 0.21 correlation, their price movements are largely independent.
Performance
HIMS vs. SNEX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HIMS achieves a 3.30% return, which is significantly lower than SNEX's 118.84% return.
HIMS
- 1D
- -5.44%
- 1M
- 41.22%
- YTD
- 3.30%
- 6M
- -4.31%
- 1Y
- -47.77%
- 3Y*
- 58.52%
- 5Y*
- 24.71%
- 10Y*
- —
SNEX
- 1D
- -0.16%
- 1M
- 23.79%
- YTD
- 118.84%
- 6M
- 115.47%
- 1Y
- 145.88%
- 3Y*
- 77.18%
- 5Y*
- 49.24%
- 10Y*
- 33.48%
HIMS vs. SNEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc. | 3.30% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
SNEX StoneX Group Inc. | 118.84% | 45.65% | 32.70% | 16.21% | 55.59% | 5.79% | 18.57% | 10.08% |
Correlation
The correlation between HIMS and SNEX is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.21 |
Fundamentals
HIMS:
$7.66B
SNEX:
$11.31B
HIMS:
-$0.05
SNEX:
$7.78
HIMS:
3.47
SNEX:
0.05
HIMS:
17.17
SNEX:
4.19
HIMS:
$2.37B
SNEX:
$152.34B
HIMS:
$1.70B
SNEX:
$47.64B
HIMS:
$16.04M
SNEX:
$2.46B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HIMS vs. SNEX — Risk / Return Rank
HIMS
SNEX
HIMS vs. SNEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and StoneX Group Inc. (SNEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HIMS | SNEX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.92 | ||
| Sortino ratioReturn per unit of downside risk | -3.76 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.52 | -0.55 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | 7.02 | -7.63 |
| Martin ratioReturn relative to average drawdown | -1.00 | 17.98 | -18.97 |
Loading charts...
Drawdowns
HIMS vs. SNEX - Drawdown Comparison
The maximum HIMS drawdown since its inception was -87.29%, smaller than the maximum SNEX drawdown of -97.89%. Use the drawdown chart below to compare losses from any high point for HIMS and SNEX.
Loading charts...
Drawdown Indicators
| HIMS | SNEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.29% | -97.89% | +10.60% |
Max Drawdown (1Y)Largest decline over 1 year | -78.06% | -20.91% | -57.15% |
Max Drawdown (3Y)Largest decline over 3 years | -78.88% | -20.91% | -57.97% |
Max Drawdown (5Y)Largest decline over 5 years | -78.88% | -24.07% | -54.81% |
Max Drawdown (10Y)Largest decline over 10 years | — | -48.65% | — |
Current DrawdownCurrent decline from peak | -51.21% | -0.16% | -51.05% |
Average DrawdownAverage peak-to-trough decline | -43.26% | -42.86% | -0.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 48.60% | 8.15% | +40.45% |
Volatility
HIMS vs. SNEX - Volatility Comparison
Hims & Hers Health, Inc. (HIMS) has a higher volatility of 23.38% compared to StoneX Group Inc. (SNEX) at 12.39%. This indicates that HIMS's price experiences larger fluctuations and is considered to be riskier than SNEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HIMS | SNEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.38% | 12.39% | +10.99% |
Volatility (6M)Calculated over the trailing 6-month period | 69.21% | 30.98% | +38.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 97.84% | 42.87% | +54.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.58% | 35.24% | +48.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.39% | 36.55% | +40.84% |
Dividends
HIMS vs. SNEX - Dividend Comparison
Neither HIMS nor SNEX has paid dividends to shareholders.
Financials
HIMS vs. SNEX - Financials Comparison
This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and StoneX Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HIMS vs. SNEX - Profitability Comparison
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
SNEX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, StoneX Group Inc. reported a gross profit of 45.35B and revenue of 45.76B. Therefore, the gross margin over that period was 99.1%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
SNEX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, StoneX Group Inc. reported an operating income of 45.32B and revenue of 45.76B, resulting in an operating margin of 99.0%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
SNEX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, StoneX Group Inc. reported a net income of 174.30M and revenue of 45.76B, resulting in a net margin of 0.4%.
Frequently Asked Questions
HIMS and SNEX have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (23.38%) compared to SNEX (12.39%). In terms of maximum drawdown, HIMS dropped -87.29% vs SNEX's -97.89%.
SNEX currently has the higher Sharpe Ratio (3.43 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HIMS and SNEX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer